DCM

DAFNA Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-390,066	Closed	-$441K	–	92
2022 Q2	$441K	Sell	390,066 -506,034	-56%	-$572K	0.12%	77
2022 Q1	$2.68M	Buy	896,100 +17,100	+2%	+$51.1K	0.7%	39
2021 Q4	$2.33M	Buy	879,000 +70,000	+9%	+$185K	0.59%	39
2021 Q3	$2.94M	Buy	809,000 +565,000	+232%	+$2.05M	0.78%	32
2021 Q2	$1.06M	Sell	244,000 -31,500	-11%	-$137K	0.22%	70
2021 Q1	$942K	Buy	+275,500	New	+$942K	0.22%	73
2020 Q3	–	Sell	-157,700	Closed	-$289K	–	86
2020 Q2	$289K	Hold	157,700	–	–	0.08%	82
2020 Q1	$246K	Hold	157,700	–	–	0.1%	75
2019 Q4	$337K	Hold	157,700	–	–	0.12%	75
2019 Q3	$295K	Buy	157,700 +20,100	+15%	+$37.6K	0.11%	78
2019 Q2	$359K	Hold	137,600	–	–	0.13%	74
2019 Q1	$354K	Hold	137,600	–	–	0.15%	69
2018 Q4	$316K	Hold	137,600	–	–	0.16%	70
2018 Q3	$442K	Hold	137,600	–	–	0.18%	59
2018 Q2	$389K	Sell	137,600 -764,333	-85%	-$2.16M	0.18%	63
2018 Q1	$3.19M	Sell	901,933 -81,545	-8%	-$289K	1.55%	24
2017 Q4	$3.82M	Buy	983,478 +540,000	+122%	+$2.1M	2.06%	17
2017 Q3	$1.13M	Hold	443,478	–	–	0.7%	43
2017 Q2	$1.21M	Sell	443,478 -30,000	-6%	-$81.9K	0.86%	38
2017 Q1	$1.57M	Buy	+473,478	New	+$1.57M	1.33%	28
2016 Q4	–	Sell	-340,000	Closed	-$1.25M	–	73
2016 Q3	$1.25M	Sell	340,000 -1,507,087	-82%	-$5.53M	0.87%	38
2016 Q2	$4.12M	Sell	1,847,087 -29,405	-2%	-$65.6K	3.26%	7
2016 Q1	$3.9M	Buy	1,876,492 +766,752	+69%	+$1.59M	3.37%	5
2015 Q4	$3.36M	Hold	1,109,740	–	–	3%	9
2015 Q3	$2.74M	Hold	1,109,740	–	–	2.72%	10
2015 Q2	$3.56M	Hold	1,109,740	–	–	3.01%	5
2015 Q1	$3.96M	Buy	1,109,740 +360,674	+48%	+$1.29M	3.04%	7
2014 Q4	$1.7M	Buy	+749,066	New	+$1.7M	1.34%	21